{
  "main_header": {
    "sid": 796559,
    "name": "Roopa Industries",
    "stock_name": "Roopa Industries",
    "full_name": "Roopa Industries Ltd",
    "name_url": "stocks-analysis/roopa-industries",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "57.14",
    "chg": 2.19,
    "chgp": "3.99%",
    "dir": 1,
    "prev_price": "54.95",
    "mcapval": "48.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530991,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE443C01010",
    "curr_date": "Apr 11, 12:48 PM",
    "curr_time": "00:13 AM",
    "bse_nse_vol": "2.89 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/roopa-industries-796559-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Roopa Industries Faces Volatility Amidst Positive Sales Growth and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roopa-industries-hits-52-week-low-amid-ongoing-stock-decline-and-market-volatility-1662373",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/RoopaIndustries_priceRelatedfactors_854051.png",
        "date": "2025-04-01 12:35:33",
        "description": "Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low amid significant volatility. Despite reporting positive sales growth and profit for three consecutive quarters, the company's long-term fundamentals appear weak, with a low return on capital and high debt levels."
      },
      {
        "title": "Roopa Industries Faces Volatility Amid Strong Sales Growth and Valuation Opportunities",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roopa-industries-hits-52-week-low-amid-ongoing-stock-decline-and-weak-fundamentals-1641214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/RoopaIndustries_priceRelatedfactors_834385.png",
        "date": "2025-03-28 10:38:16",
        "description": "Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, reaching a 52-week low. The company has underperformed the broader market over the past year, but reported strong quarterly results with a notable increase in net sales and profits, indicating potential despite ongoing challenges."
      },
      {
        "title": "Roopa Industries Reports Sales Growth Amid Financial Health Concerns and Market Sentiment Shift",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/roopa-industries-stock-downgraded-to-strong-sell-amid-debt-concerns-and-bearish-signals-1301900",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/RoopaIndustries_mojoScore_653378.png",
        "date": "2025-03-12 08:03:58",
        "description": "Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, recently adjusted its evaluation amid mixed performance indicators. In Q3 FY24-25, the company reported a significant rise in net sales and achieved its highest profit after tax. However, challenges include a low return on capital employed and a high debt to EBITDA ratio."
      },
      {
        "title": "Roopa Industries Reports Strong Sales Growth Amid Long-Term Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/roopa-industries-receives-sell-upgrade-amidst-mixed-financial-performance-and-high-debt-levels-1228966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/RoopaIndustries_mojoScore_617805.png",
        "date": "2025-03-07 08:04:05",
        "description": "Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, recently adjusted its evaluation following strong third-quarter FY24-25 results, including a 21.2% rise in net sales and record profit after tax. However, challenges remain regarding long-term financial strength and debt servicing capabilities."
      },
      {
        "title": "Roopa Industries Reports Strong Sales Growth Amid Long-Term Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/roopa-industries-stock-downgraded-to-strong-sell-amid-financial-concerns-and-bearish-trend-1148360",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/RoopaIndustries_mojoScore_560897.png",
        "date": "2025-02-28 18:27:28",
        "description": "Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, recently reported strong third-quarter FY24-25 results, with net sales of Rs 30.73 crore and a profit after tax of Rs 0.76 crore. However, challenges remain, including low capital efficiency and high debt levels, indicating mixed long-term fundamentals."
      },
      {
        "title": "Roopa Industries Faces Stock Volatility Amid Strong Long-Term Growth Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roopa-industries-reports-8-66-annual-growth-outpacing-sensex-performance-1104080",
        "imagepath": "",
        "date": "2025-02-24 10:44:26",
        "description": "Roopa Industries, a microcap player in the Pharmaceuticals & Drugs sector, has experienced notable fluctuations in its stock performance today. The company's market capitalization stands at Rs 51.91 crore, with a price-to-earnings (P/E) ratio of 26.21, which is below the industry average of 35.70.\n\nOver the past year, Roopa Industries has shown a performance increase of 8.66%, significantly outperforming the Sensex, which rose by only 1.92%. However, the stock has faced challenges recently, with a decline of 4.33% today, compared to a 1.02% drop in the Sensex. In the short term, the stock's performance over the past month has decreased by 8.27%, while the Sensex fell by 2.16%.\n\nLong-term performance metrics reveal a robust growth trajectory for Roopa Industries, with a remarkable 224.32% increase over three years and an impressive 695.18% rise over five years. Despite recent volatility, the company has main..."
      },
      {
        "title": "Roopa Industries Reports Strong Sales Growth Amid Long-Term Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/roopa-industries-downgraded-to-sell-amid-concerns-over-financial-health-1046880",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/RoopaIndustries_mojoScore_463012.png",
        "date": "2025-02-18 18:01:13",
        "description": "Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation following a strong third-quarter performance, with net sales reaching Rs 30.73 crore. However, challenges persist, including a low Return on Capital Employed and difficulties in debt servicing, indicating a complex financial landscape."
      },
      {
        "title": "Roopa Industries Reports Strong Sales Growth and Highest Profit in Five Quarters",
        "link": "https://www.marketsmojo.com/news/result-analysis/roopa-industries-reports-21-2-increase-in-net-sales-for-december-2024-1041064",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/RoopaIndustries_quaterlyResult_451841.png",
        "date": "2025-02-17 13:47:52",
        "description": "Roopa Industries has announced its financial results for the quarter ending December 2024, revealing net sales of Rs 30.73 crore, a 21.2% increase from the previous year. The company also reported a profit after tax of Rs 0.76 crore and earnings per share of Rs 0.97, both at five-quarter highs."
      },
      {
        "title": "Roopa Industries Reports Growth Amid Financial Challenges in Recent Evaluation Adjustment",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/roopa-industries-reports-75-01-growth-in-net-sales-for-fy24-25-q2-748118",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/RoopaIndustries_mojoScore_335380.png",
        "date": "2025-02-03 18:31:16",
        "description": "Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation amid positive financial results for the quarter ending September 2024. The company reported significant net sales growth and a profit after tax, although it faces challenges related to long-term financial metrics and high debt levels."
      }
    ],
    "total": 41,
    "sid": "796559",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/roopa-industries-796559"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "03-Apr-2025",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Roopa Industries Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L10100AP1985PLC005582</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>31.61</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: I V Lakshmi <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@roopaindustries.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: B Vishnu Vardhan <br/> Designation: Chief Financial Officer <br/> EmailId: cfo@roopaindustries.com</div> </div> <div> <br/> Date: 03/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Mar-2025",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Feb-2025",
      "details": "Publication of Unaudited Financial Results for the Third Quarter and Nine months ended 31st December 2024 as per SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Roopa Industries Faces Volatility Amidst Positive Sales Growth and Weak Fundamentals

2025-04-01 12:35:33

Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, hit a new 52-week low amid significant volatility. Despite reporting positive sales growth and profit for three consecutive quarters, the company's long-term fundamentals appear weak, with a low return on capital and high debt levels.

Read More

Roopa Industries Faces Volatility Amid Strong Sales Growth and Valuation Opportunities

2025-03-28 10:38:16

Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, reaching a 52-week low. The company has underperformed the broader market over the past year, but reported strong quarterly results with a notable increase in net sales and profits, indicating potential despite ongoing challenges.

Read More

Roopa Industries Reports Sales Growth Amid Financial Health Concerns and Market Sentiment Shift

2025-03-12 08:03:58

Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, recently adjusted its evaluation amid mixed performance indicators. In Q3 FY24-25, the company reported a significant rise in net sales and achieved its highest profit after tax. However, challenges include a low return on capital employed and a high debt to EBITDA ratio.

Read More

Roopa Industries Reports Strong Sales Growth Amid Long-Term Financial Concerns

2025-03-07 08:04:05

Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, recently adjusted its evaluation following strong third-quarter FY24-25 results, including a 21.2% rise in net sales and record profit after tax. However, challenges remain regarding long-term financial strength and debt servicing capabilities.

Read More

Roopa Industries Reports Strong Sales Growth Amid Long-Term Financial Concerns

2025-02-28 18:27:28

Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, recently reported strong third-quarter FY24-25 results, with net sales of Rs 30.73 crore and a profit after tax of Rs 0.76 crore. However, challenges remain, including low capital efficiency and high debt levels, indicating mixed long-term fundamentals.

Read More

Roopa Industries Faces Stock Volatility Amid Strong Long-Term Growth Trends

2025-02-24 10:44:26

Roopa Industries, a microcap player in the Pharmaceuticals & Drugs sector, has experienced notable fluctuations in its stock performance today. The company's market capitalization stands at Rs 51.91 crore, with a price-to-earnings (P/E) ratio of 26.21, which is below the industry average of 35.70. Over the past year, Roopa Industries has shown a performance increase of 8.66%, significantly outperforming the Sensex, which rose by only 1.92%. However, the stock has faced challenges recently, with a decline of 4.33% today, compared to a 1.02% drop in the Sensex. In the short term, the stock's performance over the past month has decreased by 8.27%, while the Sensex fell by 2.16%. Long-term performance metrics reveal a robust growth trajectory for Roopa Industries, with a remarkable 224.32% increase over three years and an impressive 695.18% rise over five years. Despite recent volatility, the company has main...

Read More

Roopa Industries Reports Strong Sales Growth Amid Long-Term Financial Challenges

2025-02-18 18:01:13

Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation following a strong third-quarter performance, with net sales reaching Rs 30.73 crore. However, challenges persist, including a low Return on Capital Employed and difficulties in debt servicing, indicating a complex financial landscape.

Read More

Roopa Industries Reports Strong Sales Growth and Highest Profit in Five Quarters

2025-02-17 13:47:52

Roopa Industries has announced its financial results for the quarter ending December 2024, revealing net sales of Rs 30.73 crore, a 21.2% increase from the previous year. The company also reported a profit after tax of Rs 0.76 crore and earnings per share of Rs 0.97, both at five-quarter highs.

Read More

Roopa Industries Reports Growth Amid Financial Challenges in Recent Evaluation Adjustment

2025-02-03 18:31:16

Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation amid positive financial results for the quarter ending September 2024. The company reported significant net sales growth and a profit after tax, although it faces challenges related to long-term financial metrics and high debt levels.

Read More

View All News